United Services Automobile Association Catalent, Inc. Transaction History

United Services Automobile Association

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$47.45 - $58.05 $1.05 Million - $1.29 Million	-22,205 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$29.95 - $46.34 $62,176 - $96,201	-2,076 Reduced 8.55%	22,205 $692,000
Q3 2018 Nov 13, 2018	BUY	$40.12 - $45.55 $22,306 - $25,325	556 Added 2.34%	24,281 $1.11 Million
Q2 2018 Aug 10, 2018	BUY	$38.72 - $42.52 $54,904 - $60,293	1,418 Added 6.36%	23,725 $994,000
Q1 2018 May 14, 2018	BUY	$39.4 - $47.39 $878,895 - $1.06 Million	22,307 New	22,307 $916,000

513

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of United Services Automobile Association, based on Form 13F filings with the SEC.

Stay updated on United Services Automobile Association with notifications on news.